Skillman, NJ, United States of America

Robert G Hindes

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert G Hindes

Introduction

Robert G Hindes is a notable inventor based in Skillman, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis C virus (HCV) infection. With a total of 2 patents to his name, his work has the potential to impact many lives.

Latest Patents

Hindes' latest patents focus on compositions and methods for treating hepatitis C virus. One of the key innovations includes a composition and unit dosage form for the treatment of HCV infection, which comprises GS-7977 and at least one pharmaceutically acceptable excipient. The patent also outlines methods for making this composition and dosage form. Furthermore, it describes a method of treating a subject infected with HCV, which involves administering an effective amount of GS-7977 and ribavirin. Notably, this method can produce an undetectable amount of HCV RNA in the subject for at least 12 weeks after treatment.

Career Highlights

Robert G Hindes is currently associated with Gilead Pharmasset LLC, where he continues to innovate in the pharmaceutical field. His work has been instrumental in developing effective treatments for viral infections, showcasing his dedication to improving public health.

Collaborations

Hindes has collaborated with notable colleagues such as Darryl G Cleary and Charles J Reynolds. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Robert G Hindes is a prominent inventor whose work in treating hepatitis C virus has the potential to change lives. His contributions to the field of medicine through innovative patents reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…